Molecular Cloning and Expression of Megakaryocyte Potentiating Factor cDNA (*)

The human megakaryocyte potentiating factor (hMPF) has been previously purified from a culture supernatant of human pancreatic cancer cells HPC-Y5 (Yamaguchi, N., Hattori, K., Oh-eda, M., Kojima, T., Imai, N., and Ochi, N.(1994) J. Biol. Chem. 269, 805-808). We have now isolated hMPF cDNA from a HPC-Y5 cDNA library using polymerase chain reaction and plaque hybridization methods. The hMPF cDNA encodes a polypeptide consisting of 622 amino acids, including a signal peptide of 33 amino acids, and with a deduced molecular mass of 68 kDa, although HPC-Y5 cells secrete a 33-kDa form of hMPF. Human MPF does not show any significant homology with other previously described sequences. The cDNA was expressed in COS-7 and Chinese hamster ovary (CHO) cells, and megakaryocyte potentiating activity was detected in their culture supernatant. The COS-7 cells secreted only a 33-kDa recombinant hMPF, whereas an additional 30-kDa form was detected in the culture medium of CHO cells. The 33-kDa rhMPF purified from CHO cells showed megakaryocyte potentiating activity, but not the purified 30-kDa rhMPF. The difference in structure and activity between the 33- and 30-kDa forms of hMPF was ascribed to the existence in the 33-kDa form of the C-terminal 25 amino acid residues.

[1]  N. Yamaguchi,et al.  A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5. , 1994, The Journal of biological chemistry.

[2]  Y. Katakura,et al.  Unfolding/refolding studies on bovine beta-lactoglobulin with monoclonal antibodies as probes. Does a renatured protein completely refold? , 1993, The Journal of biological chemistry.

[3]  K. Nakayama,et al.  Positional and additive effects of basic amino acids on processing of precursor proteins within the constitutive secretory pathway , 1993, FEBS letters.

[4]  R. Hoffman,et al.  Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia. , 1992, Blood.

[5]  T. Watanabe,et al.  Sequence requirements for precursor cleavage within the constitutive secretory pathway. , 1992, The Journal of biological chemistry.

[6]  J. Böhm,et al.  Carboxy-terminal truncated rhuIFN-gamma with a substitution of Gln133 or Ser132 to leucine leads to higher biological activity than in the wild type. , 1991, European journal of biochemistry.

[7]  S. Nagata,et al.  pEF-BOS, a powerful mammalian expression vector. , 1990, Nucleic acids research.

[8]  D. Shortle,et al.  Residual structure in large fragments of staphylococcal nuclease: effects of amino acid substitutions. , 1989, Biochemistry.

[9]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[10]  E. Chen,et al.  A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. , 1987, Science.

[11]  P. Familletti,et al.  Structural characterization of human interferon γ Heterogeneity of the carboxyl terminus , 1987 .

[12]  B. Seed.  An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2 , 1987, Nature.

[13]  R. Eddy,et al.  cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines , 1986, Nature.

[14]  Anita B. Roberts,et al.  Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells , 1985, Nature.

[15]  E. Rinderknecht,et al.  Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation. , 1984, The Journal of biological chemistry.

[16]  B. Hoffman,et al.  A simple and very efficient method for generating cDNA libraries. , 1983, Gene.

[17]  W. Rutter,et al.  Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor , 1983, Nature.

[18]  D. J. Nelson,et al.  Two‐factor requirement for murine megakaryocyte colony formation , 1982, Journal of cellular physiology.

[19]  S. Pestka,et al.  Amino acid sequence of a human leukocyte interferon. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Ralph,et al.  Cell interactions influencing murine marrow megakaryocytes: nature of the potentiator cell in bone marrow. , 1981, Blood.

[21]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[22]  W. D. Benton,et al.  Screening lambdagt recombinant clones by hybridization to single plaques in situ. , 1977, Science.

[23]  H. Macdonald,et al.  Growth of mouse megakaryocyte colonies in vitro. , 1975, Proceedings of the National Academy of Sciences of the United States of America.